YONGAN PHARMACEUTICAL: Plans to acquire minority shareholder equity in its controlling subsidiary for 27 million yuan

Zhitong
2025.09.24 09:12

YONGAN PHARMACEUTICAL announced that the company plans to use its own funds of 27 million yuan to acquire a total of 49.20% equity in Ling'an Technology Co., Ltd. held by minority shareholders Zhang Yong, Xia Changpei, and Dai Liang. This move aims to further strengthen control over Ling'an Technology, accelerate its market layout in the business field, and align with the company's overall strategic planning. After the transaction is completed, Ling'an Technology will become a wholly-owned subsidiary of the company. The source of funds is from its own funds and will not affect the company's normal production and operations

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer